SUMATRIPTAN SUCCINATE (AUTOINJECTOR) Drug Patent Profile
✉ Email this page to a colleague
When do Sumatriptan Succinate (autoinjector) patents expire, and what generic alternatives are available?
Sumatriptan Succinate (autoinjector) is a drug marketed by Onesource Specialty and is included in one NDA.
The generic ingredient in SUMATRIPTAN SUCCINATE (AUTOINJECTOR) is sumatriptan succinate. Thirty-six suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Sumatriptan Succinate (autoinjector)
A generic version of SUMATRIPTAN SUCCINATE (AUTOINJECTOR) was approved as sumatriptan succinate by HIKMA on February 6th, 2009.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)?
- What are the global sales for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)?
- What is Average Wholesale Price for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)?
Summary for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
US Patents and Regulatory Information for SUMATRIPTAN SUCCINATE (AUTOINJECTOR)
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Onesource Specialty | SUMATRIPTAN SUCCINATE (AUTOINJECTOR) | sumatriptan succinate | INJECTABLE;SUBCUTANEOUS | 090314-002 | Jan 30, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
